Moonshot

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded GLP-1 medicationCompounded · not FDA-approved

What they publish

Moonshot publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

From $195/month all-inclusive with medication included; a $150/month figure also published (as published)

Medication cost

Publishes retail Ozempic, Wegovy or Mounjaro without insurance at $1,000-$1,500/month as comparison context (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• All-inclusive pricing with medication included makes the figure directly comparable rather than a membership floor.
• The retail comparison it publishes ($1,000-$1,500/month) is accurate rather than inflated, which is more than many competitors manage.
• The comparison is brand versus compounded, so it is not a like-for-like saving — see our brand vs compounded guide.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Confirm the $195 holds as your dose escalates.
• The retail comparison is against brand-name medication, not against other compounded providers.
• Ask which pharmacy compounds it and whether it is 503A or 503B.